These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 8192689)

  • 21. Cognitive effects of GABAergic antiepileptic drugs.
    Kälviäinen R
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():458-64. PubMed ID: 10689494
    [No Abstract]   [Full Text] [Related]  

  • 22. Behavioral effects of vigabatrin correlated with whole brain gamma-aminobutyric acid metabolism in audiogenic sensitive rats.
    Engelborghs S; Pickut BA; D'Hooge R; Wiechert P; Haegele K; De Deyn PP
    Arzneimittelforschung; 1998 Jul; 48(7):713-6. PubMed ID: 9706369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of GABAergic systems in the mechanism of action of antiepileptic drugs.
    Lloyd KG
    Therapie; 1983; 38(4):355-62. PubMed ID: 6359564
    [No Abstract]   [Full Text] [Related]  

  • 24. Regulation of excitation by GABA neurotransmission: focus on metabolism and transport.
    Madsen KK; Larsson OM; Schousboe A
    Results Probl Cell Differ; 2008; 44():201-21. PubMed ID: 17579816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Receptor mechanisms of antiepileptic drug action].
    Janiec K
    Przegl Lek; 1994; 51(11):475-9. PubMed ID: 7871193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure of GABA-aminotransferase, a target for antiepileptic drug therapy.
    Storici P; Capitani G; De Biase D; Moser M; John RA; Jansonius JN; Schirmer T
    Biochemistry; 1999 Jul; 38(27):8628-34. PubMed ID: 10393538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [GABAergic mechanisms in generalized epilepsies: the neuroanatomical dimension].
    Depaulis A; Deransart C; Vergnes M; Marescaux C
    Rev Neurol (Paris); 1997; 153 Suppl 1():S8-13. PubMed ID: 9686242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antiepileptic drug levetiracetam stabilizes the human epileptic GABAA receptors upon repetitive activation.
    Palma E; Ragozzino D; Di Angelantonio S; Mascia A; Maiolino F; Manfredi M; Cantore G; Esposito V; Di Gennaro G; Quarato P; Miledi R; Eusebi F
    Epilepsia; 2007 Oct; 48(10):1842-9. PubMed ID: 17521347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GABAergic Synchronization in Epilepsy.
    Khazipov R
    Cold Spring Harb Perspect Med; 2016 Jan; 6(2):a022764. PubMed ID: 26747834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.
    Miczek KA; Fish EW; De Bold JF; De Almeida RM
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The new generation of GABA enhancers. Potential in the treatment of epilepsy.
    Czuczwar SJ; Patsalos PN
    CNS Drugs; 2001; 15(5):339-50. PubMed ID: 11475940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vigabatrin.
    Calli J; Farrington E
    Pediatr Nurs; 1998; 24(4):357-61. PubMed ID: 9849270
    [No Abstract]   [Full Text] [Related]  

  • 33. [Efficacy of vigabatrin associated with carbamazepine in the treatment of epilepsy. Follow up 1993-1996].
    De Romanis F; Sopranzi N
    Clin Ter; 1998; 149(2):131-4. PubMed ID: 9780478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antiepileptic drugs: mechanism of action].
    Mercadé Cerdá JM
    Neurologia; 1996 Dec; 11 Suppl 4():93-9. PubMed ID: 9052961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gamma aminobutyric acid--its function, disorders and their sequelae].
    De Luka SR; Protić S; Vrbaski SR
    Med Pregl; 1998; 51(7-8):319-24. PubMed ID: 9769665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The neurochemistry of epilepsy, inhibitory neurotransmission and experimental models: new perspectives].
    de Cabo-de la Vega C; Villanueva-Hernández P; Prieto-Martín A
    Rev Neurol; 2006 Feb 1-15; 42(3):159-68. PubMed ID: 16475138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GABA, gamma-hydroxybutyric acid, and neurological disease.
    Wong CG; Bottiglieri T; Snead OC
    Ann Neurol; 2003; 54 Suppl 6():S3-12. PubMed ID: 12891648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The peripheral GABAergic system as a target in endocrine disorders.
    Gladkevich A; Korf J; Hakobyan VP; Melkonyan KV
    Auton Neurosci; 2006 Jan; 124(1-2):1-8. PubMed ID: 16338174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-clinical studies with the GABAergic compounds vigabatrin and tiagabine.
    Sills GJ
    Epileptic Disord; 2003 Mar; 5(1):51-6. PubMed ID: 12773297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticonvulsants: aspects of their mechanisms of action.
    Söderpalm B
    Eur J Pain; 2002; 6 Suppl A():3-9. PubMed ID: 11888234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.